MCTA
Income statement / Annual
Last year (2024), Charming Medical Limited Class A Ordinary Shares's total revenue was $6.22 M,
an increase of 3.43% from the previous year.
In 2024, Charming Medical Limited Class A Ordinary Shares's net income was $1.20 M.
See Charming Medical Limited Class A Ordinary Shares,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
03/31/2025 |
03/31/2024 |
03/31/2023 |
| Operating Revenue |
$6.22 M |
$6.02 M |
$3.53 M |
| Cost of Revenue |
$2.04 M
|
$2.10 M
|
$2.04 M
|
| Gross Profit |
$4.18 M
|
$3.91 M
|
$1.49 M
|
| Gross Profit Ratio |
0.67
|
0.65
|
0.42
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$1.32 M
|
$1.49 M
|
$996.95 K
|
| Selling & Marketing Expenses |
$999.35 K
|
$859.47 K
|
$664.88 K
|
| Selling, General & Administrative Expenses |
$2.32 M
|
$2.35 M
|
$1.66 M
|
| Other Expenses |
$474.14 K
|
$555.41 K
|
$353.39 K
|
| Operating Expenses |
$2.79 M
|
$2.91 M
|
$2.02 M
|
| Cost And Expenses |
$4.83 M
|
$5.01 M
|
$4.05 M
|
| Interest Income |
$64.14 K
|
$19.51 K
|
$10.29 K
|
| Interest Expense |
$20.87 K
|
$26.05 K
|
$20.26 K
|
| Depreciation & Amortization |
$263.45 K
|
$391.70 K
|
$211.08 K
|
| EBITDA |
$1.72 M |
$1.42 M |
-$189.13 K |
| EBITDA Ratio |
0.28
|
0.24
|
-0.05
|
| Operating Income Ratio |
0.22
|
0.17
|
-0.15
|
| Total Other Income/Expenses Net |
$46.23 K
|
-$5.35 K
|
$100.87 K
|
| Income Before Tax |
$1.44 M
|
$1.00 M
|
-$420.47 K
|
| Income Before Tax Ratio |
0.23
|
0.17
|
-0.12
|
| Income Tax Expense |
$236.08 K
|
$181.75 K
|
-$84.86 K
|
| Net Income |
$1.20 M
|
$777.81 K
|
-$305.12 K
|
| Net Income Ratio |
0.19
|
0.13
|
-0.09
|
| EPS |
0.0708 |
0.0459 |
-0.018 |
| EPS Diluted |
0.0708 |
0.0459 |
-0.018 |
| Weighted Average Shares Out |
$16.94 M
|
$16.94 M
|
$16.94 M
|
| Weighted Average Shares Out Diluted |
$16.94 M
|
$16.94 M
|
$16.94 M
|
| Link |
|
|
|
